Exousia Bio (LMMY) Total Current Liabilities (2023 - 2025)

Exousia Bio has disclosed Total Current Liabilities across 3 years of filings, most recently posting $261023.0 for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $261023.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was $261023.0 (changed N/A YoY), and the FY2024 annual result was $14169.0, up 292.49% from the prior year.
• Total Current Liabilities came in at $261023.0 for Q4 2025 at Exousia Bio, up from $35314.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $261023.0 in Q4 2025 to a low of $3000.0 in Q1 2023.
• The 3-year median for Total Current Liabilities is $9819.0 (2024), against an average of $39384.8.
• Across the five-year window, Total Current Liabilities jumped 314.21% in 2024 and surged 105.68% in 2025, its largest moves.
• Exousia Bio's Total Current Liabilities stood at $6214.0 in 2023, then surged by 176.3% to $17169.0 in 2024, then soared by 1420.32% to $261023.0 in 2025.
• The last three Total Current Liabilities figures came in at $261023.0 (Q4 2025), $35314.0 (Q3 2025), and $17169.0 (Q3 2024), per Business Quant data.